Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
about
Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunityAdoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regressionTreatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells.Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.Adoptive immunotherapy of cancer using CD4(+) T cells.Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation.Tumor regulatory T cells potently abrogate antitumor immunity.Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity.
P2860
Q27318672-317233CD-25C9-4EC2-941D-D69C859807D1Q30496580-33C3F98C-58DC-4DA4-84AB-0A5CADB8CD39Q34041058-12E35F00-3013-4014-B38F-E72ACC448E31Q35059053-9BE77133-680B-46F3-9F92-1953FA810662Q35146131-716AECA5-19ED-43FD-A552-814A36DDFE0FQ35840314-3F842B42-8258-4575-A3DB-975EC55E6C48Q35861249-A7F136E5-DAF8-4392-97C9-3C99495D9B58Q37086932-5EB86A29-830D-4A13-9BA8-5ECBDE7814D6Q37107843-D4165B14-FB02-4B92-94DE-A5BB7D8F9137Q37275304-30821D29-9606-427F-AB67-681C2727940BQ37317178-5EAE343E-ADC8-4CAF-8A3E-8797F442665FQ37317190-BB86D35B-6FCD-4A5B-AE27-61A60C38719CQ37578705-9FB6972D-6698-4350-8F65-5AE6B86CCB73Q41783600-6CC3BE31-8ECE-4D6B-B1A1-C73C7BC94783Q44473706-A18DACA2-A9F4-4186-97EF-D71275A8AC3EQ48170351-33845AB5-C80B-4E2C-814A-BE339FD72223
P2860
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
@en
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
@nl
type
label
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
@en
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
@nl
prefLabel
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
@en
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
@nl
P2093
P2860
P1476
Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells
@en
P2093
Janet Chen
Louis D Falo
Zhaoyang You
Zuqiang Liu
P2860
P304
P356
10.4049/JIMMUNOL.181.6.4363
P407
P577
2008-09-01T00:00:00Z